KZIA · Kazia Therapeutics Ltd
Market Cap
$155.18M
Shares
11.43M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-28 | — | |
| 6-K | 2026-08-27 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-04-27 | — | |
| 6-K | 2026-04-15 | — | |
| 6-K | 2026-04-13 | — | |
| 6-K | 2026-03-31 | — | |
| 6-K | 2026-03-30 | 2025-12-31 | |
| 6-K | 2026-03-19 | 2025-12-31 | |
| 6-K | 2026-01-27 | — | |
| 6-K | 2025-12-19 | — | |
| 6-K | 2025-12-10 | — | |
| 6-K | 2025-12-05 | — | |
| 6-K | 2025-12-02 | — | |
| 6-K | 2025-11-18 | — | |
| 20-F | 2025-11-07 | 2025-06-30 | |
| 6-K | 2025-10-07 | — | |
| 6-K | 2025-10-02 | — | |
| 6-K | 2025-09-11 | — | |
| 6-K | 2025-08-01 | — | |
| 6-K | 2025-07-25 | — | |
| 6-K | 2025-07-09 | — | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-06-10 | 2024-12-31 | |
| 6-K | 2025-06-05 | — | |
| 6-K | 2025-05-28 | — | |
| 6-K | 2025-05-15 | — | |
| 6-K | 2025-04-15 | — | |
| 6-K | 2025-03-31 | — | |
| 6-K | 2025-03-13 | 2025-03-12 | |
| 6-K | 2025-02-20 | — | |
| 6-K | 2025-02-03 | — | |
| 6-K | 2025-01-30 | — | |
| 6-K | 2025-01-13 | — | |
| 6-K | 2024-12-31 | — | |
| 6-K | 2024-12-11 | — | |
| 20-F | 2024-11-15 | 2024-06-30 | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-04 | — | |
| 6-K/A | 2024-10-24 | — | |
| 6-K | 2024-10-15 | — | |
| 6-K | 2024-10-02 | — | |
| 6-K | 2024-09-23 | — | |
| 6-K | 2024-09-13 | — | |
| 6-K | 2024-07-10 | — | |
| 6-K | 2024-06-24 | — | |
| 6-K | 2024-05-23 | — | |
| 6-K | 2024-05-17 | — |
Showing 1–50 of 167 filings
Key facts
CIK
1075880
CUSIP
48669G303
13F (30d)
35 filings
34 filers
Visit website
Investor relations